C-RAD AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0002016352
SEK
31.60
-2.55 (-7.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
CellaVision AB
C-RAD AB
Surgical Science Sweden AB
Devyser Diagnostics AB
MedCap AB
Smart Eye AB
Sedana Medical AB
Genovis AB
Doxa AB
Bactiguard Holding AB
SyntheticMR AB

Why is C-RAD AB ?

1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 29.86
2
Healthy long term growth as Net Sales has grown by an annual rate of 18.21% and Operating profit at 82.28%
3
Negative results in Jun 25
  • INTEREST(HY) At SEK 21 MM has Grown at 356.52%
  • PRE-TAX PROFIT(Q) At SEK 5.1 MM has Fallen at -62.22%
  • NET PROFIT(Q) At SEK 4 MM has Fallen at -62.26%
4
With ROE of 7.56%, it has a expensive valuation with a 3.22 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -0.78%, its profits have fallen by -59.7%
5
Below par performance in long term as well as near term
  • Along with generating -0.78% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to C-RAD AB should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is C-RAD AB for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
C-RAD AB
-100.0%
-0.96
29.71%
OMX Stockholm 30
17.06%
0.95
17.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
18.21%
EBIT Growth (5y)
82.28%
EBIT to Interest (avg)
29.86
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.49
Sales to Capital Employed (avg)
1.47
Tax Ratio
39.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
32.53%
ROE (avg)
10.39%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
43
Industry P/E
Price to Book Value
3.22
EV to EBIT
13.38
EV to EBITDA
11.95
EV to Capital Employed
5.13
EV to Sales
2.11
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
38.32%
ROE (Latest)
7.56%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
CASH AND EQV(HY)

Highest at SEK 319.2 MM

-27What is not working for the Company
INTEREST(HY)

At SEK 21 MM has Grown at 356.52%

PRE-TAX PROFIT(Q)

At SEK 5.1 MM has Fallen at -62.22%

NET PROFIT(Q)

At SEK 4 MM has Fallen at -62.26%

ROCE(HY)

Lowest at 8.01%

RAW MATERIAL COST(Y)

Grown by 44.35% (YoY

OPERATING PROFIT(Q)

Lowest at SEK 12.2 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 11.6 %

Here's what is working for C-RAD AB

Cash and Eqv
Highest at SEK 319.2 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for C-RAD AB

Interest
At SEK 21 MM has Grown at 356.52%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Pre-Tax Profit
At SEK 5.1 MM has Fallen at -62.22%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (SEK MM)

Net Profit
At SEK 4 MM has Fallen at -62.26%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (SEK MM)

Operating Profit
Lowest at SEK 12.2 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (SEK MM)

Operating Profit Margin
Lowest at 11.6 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Raw Material Cost
Grown by 44.35% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales